Author

H. Sivakumaran

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:CRISPR screen· 1 Approach:deep learning· 1

Frequent Co-Authors

H. Gowda· 2 shared J. D. French· 2 shared J. Rosenbluh· 2 shared S. Kaufmann· 2 shared S. L. Edwards· 2 shared A. CAMPOS· 1 shared A. Civitarese· 1 shared A. Hatzipantelis· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. Gowda

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CRISPR-Cas13d screens identify KILR a breast cancer risk-associated lncRNA that regulates DNA replication and repair.

L. Wang, M. Bitar, X. Lu, S. Jacquelin, S. Nair, H. Sivakumaran, K. M. Hillman, S. Kaufmann, R. Ziegman, F. Casciello, H. Gowda, J. Rosenbluh, S. L. Edwards, J. D. French

The paper identifies KILR, a breast cancer risk-associated lncRNA, and shows it regulates DNA replication and repair by sequestering RPA1.

bioRxiv · Nov 16, 2023 · PreprintCancer Biology

Regulation of Non-Canonical Proteins Encoded by Small Open Reading Frames via the Nonsense-Mediated Decay Pathway.

P. PERIASAMY, C. JOSEPH, A. CAMPOS, S. RAJANDRAN, C. Batho, J. E. Hudson, H. Sivakumaran, H. Kore, K. Datta, J. Yeong, H. Gowda

This study investigates how UPF1 knockdown affects non-canonical/mutant protein expression and reveals its role in suppressing neoantigen availability through the NMD pathway in cancer.

bioRxiv · Aug 26, 2023 · PreprintCell Biology

CRISPR screens identify gene targets and drug repositioning opportunities at breast cancer risk loci

N. K. Tuano, J. Beesley, M. Manning, W. Shi, L. Malver-Ortega, J. Paynter, D. Black, A. Civitarese, K. McCue, A. Hatzipantelis, K. Hillman, S. Kaufmann, H. Sivakumaran, J. M. Polo, R. Reddel, , J. Rosenbluh

bioRxiv · Sep 7, 2021 · PreprintCancer Biology